tiprankstipranks
Advertisement
Advertisement

FR:IPN Stock Latest News

RatingsBenjamin Jackson Reiterates Hold on Ipsen as Corabotase Data Show Limited Differentiation from Next‑Gen Neurotoxins
4d ago
PremiumCompany Announcements
Ipsen’s corabotase shows prolonged effect and high satisfaction in phase II glabellar lines trial
5d ago
Ipsen (0MH6) Declares Q2 Dividend: Important Details for Shareholders
PremiumDividends
Ipsen (0MH6) Declares Q2 Dividend: Important Details for Shareholders
1y ago
Ipsen’s Strategic Move in Cancer Therapy Development
PremiumCompany Announcements
Ipsen’s Strategic Move in Cancer Therapy Development
1y ago
Ipsen’s Bylvay Shows Promise in Liver Disease Treatment
PremiumCompany Announcements
Ipsen’s Bylvay Shows Promise in Liver Disease Treatment
2y ago
Ipsen’s Iqirvo Gains Ground in PBC Treatment
PremiumCompany AnnouncementsIpsen’s Iqirvo Gains Ground in PBC Treatment
2y ago
Ipsen Wins Second Shingo Prize for Excellence
Premium
Company Announcements
Ipsen Wins Second Shingo Prize for Excellence
2y ago
Ipsen’s Kayfanda® Gets EU Approval for Rare Liver Disease
Premium
Company Announcements
Ipsen’s Kayfanda® Gets EU Approval for Rare Liver Disease
2y ago
Ipsen’s New PBC Treatment Iqirvo Gains EU Approval
PremiumCompany Announcements
Ipsen’s New PBC Treatment Iqirvo Gains EU Approval
2y ago
Ipsen Nears EU Approval for Liver Disease Drugs
PremiumCompany Announcements
Ipsen Nears EU Approval for Liver Disease Drugs
2y ago
Ipsen Secures Deal for Promising Cancer Drug FS001
PremiumCompany Announcements
Ipsen Secures Deal for Promising Cancer Drug FS001
2y ago
Ipsen Eyes Expanded Market for Cabometyx After Trial Success
PremiumCompany Announcements
Ipsen Eyes Expanded Market for Cabometyx After Trial Success
2y ago
Ipsen’s Iqirvo® Wins FDA Nod for Liver Disease
PremiumCompany AnnouncementsIpsen’s Iqirvo® Wins FDA Nod for Liver Disease
2y ago
Ipsen Bolsters Oncology Research with Marengo
Premium
Company Announcements
Ipsen Bolsters Oncology Research with Marengo
2y ago
Ipsen Welcomes New EVP of Corporate Affairs
Premium
Company Announcements
Ipsen Welcomes New EVP of Corporate Affairs
2y ago
Ipsen’s Elafibranor Shows Promise for PBC Treatment
PremiumCompany Announcements
Ipsen’s Elafibranor Shows Promise for PBC Treatment
2y ago
Ipsen (0MH6) Declares Q2 Dividend: Important Details for Shareholders
PremiumDividends
Ipsen (0MH6) Declares Q2 Dividend: Important Details for Shareholders
2y ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >